603 related articles for article (PubMed ID: 27090863)
1. Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial.
Boostanfar R; Gates D; Guan Y; Gordon K; McCrary Sisk C; Stegmann BJ
Fertil Steril; 2016 Aug; 106(2):300-305.e5. PubMed ID: 27090863
[TBL] [Abstract][Full Text] [Related]
2. Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.
Boostanfar R; Shapiro B; Levy M; Rosenwaks Z; Witjes H; Stegmann BJ; Elbers J; Gordon K; Mannaerts B;
Fertil Steril; 2015 Jul; 104(1):94-103.e1. PubMed ID: 26003273
[TBL] [Abstract][Full Text] [Related]
3. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
4. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
[TBL] [Abstract][Full Text] [Related]
5. A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone.
Boostanfar R; Mannaerts B; Pang S; Fernandez-Sanchez M; Witjes H; Devroey P;
Fertil Steril; 2012 Jun; 97(6):1351-8. PubMed ID: 22459628
[TBL] [Abstract][Full Text] [Related]
6. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.
Mahmoud Youssef MA; van Wely M; Aboulfoutouh I; El-Khyat W; van der Veen F; Al-Inany H
Fertil Steril; 2012 Apr; 97(4):876-85. PubMed ID: 22277766
[TBL] [Abstract][Full Text] [Related]
7. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
8. Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome.
Bonduelle M; Mannaerts B; Leader A; Bergh C; Passier D; Devroey P
Hum Reprod; 2012 Jul; 27(7):2177-85. PubMed ID: 22587997
[TBL] [Abstract][Full Text] [Related]
9. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study.
Gerber RS; Fazzari M; Kappy M; Cohen A; Galperin S; Lieman H; Jindal S; Buyuk E
Fertil Steril; 2020 Dec; 114(6):1225-1231. PubMed ID: 33012553
[TBL] [Abstract][Full Text] [Related]
11. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
[TBL] [Abstract][Full Text] [Related]
12. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
[TBL] [Abstract][Full Text] [Related]
13. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.
Devroey P; Pellicer A; Nyboe Andersen A; Arce JC;
Fertil Steril; 2012 Mar; 97(3):561-71. PubMed ID: 22244781
[TBL] [Abstract][Full Text] [Related]
14. High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers.
Munch EM; Sparks AE; Zimmerman MB; Van Voorhis BJ; Duran EH
Hum Reprod; 2017 Jul; 32(7):1402-1409. PubMed ID: 28472321
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients.
Hwang JL; Chen SU; Chen HJ; Chen HF; Yang YS; Chang CH; Seow KM; Tzeng CR; Lin YH
J Formos Med Assoc; 2018 Jun; 117(6):535-540. PubMed ID: 28830648
[TBL] [Abstract][Full Text] [Related]
16. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
17. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.
Blockeel C; Polyzos NP; Derksen L; De Brucker M; Vloeberghs V; van de Vijver A; De Vos M; Tournaye H
Hum Reprod; 2014 Jul; 29(7):1500-7. PubMed ID: 24813196
[TBL] [Abstract][Full Text] [Related]
18. [Corifollitropin alfa in women stimulated for the first time in in vitro fertilization programme].
Vraná-Mardešićová N; Vobořil J; Melicharová L; Jelínková L; Vilímová Š; Mardešić T
Ceska Gynekol; 2017; 82(5):362-365. PubMed ID: 29020783
[TBL] [Abstract][Full Text] [Related]
19. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
[TBL] [Abstract][Full Text] [Related]
20. Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
Witz CA; Daftary GS; Doody KJ; Park JK; Seifu Y; Yankov VI; Heiser PW;
Fertil Steril; 2020 Aug; 114(2):321-330. PubMed ID: 32416978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
